Clinical Trial Update: Be SMART NIS, Moderate to Servere Asthma Patient Observation

View source ↗

Summary

AstraZeneca-sponsored non-interventional observational study (Be SMART NIS) in adults with moderate to severe asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED